Patent ID: 8431533

Claim:
A fusion peptide comprising as component (I) N-terminally a sequence according to formula I His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala -Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-X (I), wherein X is NH 2 or Gly-OH, or a sequence having at least 95% sequence identity with the sequence according to formula I; and as component (II) C-terminally a peptide sequence containing SEQ ID NO: 26 or a sequence having at least 90% sequence identity with SEQ ID NO: 26, and its pharmaceutically active salts, wherein the fusion peptide has insulinotropic activity.